This is a preliminary report on BioLineRx’s security posture. If you want in-depth, always up-to-date reports on BioLineRx and millions of other companies, consider booking a demo with us. UpGuard is the new standard in third-party risk management and attack surface management. Our security ratings engine monitors billions of data points each day.

UpGuard Security Rating

/ 950
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely BioLineRx has good security practices.

Company info

Modi'in-Maccabim-Re'ut, Center District, Israel.
Last updated
Last updated
Last updated today

Security report for BioLineRx

BioLineRx, or BioLine, is a publicly traded drug development company that seeks to discover compounds for disease treatment and develop them into commercializable drugs. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.

BioLineRx Data Breaches and Security News

Relevant news, breaches and security articles relating to BioLineRx.
Coming soon.
No recent security news.

More security reports

Compare BioLineRx's security performance with other companies.
Deliver icon

Sign up to our newsletter

Get the latest curated cybersecurity news, breaches, events and updates in your inbox every week.
Abstract shapeAbstract shape
Free instant security score

How secure is your organization?

Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
  • Check icon
    Instant insights you can act on immediately
  • Check icon
    13 risk factors, including email security, SSL, DNS health, open ports and common vulnerabilities
Website Security scan resultsWebsite Security scan ratingAbstract shape

Book a free demo

Book a free, personalized onboarding call with one of our cybersecurity experts.